Venture Capital Investments

Erytech

Erytech Pharma is developing technology enabling active principles to be encapsulated inside red blood corpuscles in order to avoid the risk of allergic reactions to certain molecules, "protecting" them against the immune system, prolonging their life within the  organism, and/or facilitating their delivery to specific organs.